Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit
03. Dezember 2024 07:00 ET
|
Chemomab Therapeutics
Chemomab management is participating in the Oppenheimer Movers in Rare Disease Summit on Dec 13, 2024 at the Westin Grand Central in NYC.
Immuneering Announces Participation in February Investor Conferences
01. Februar 2024 08:00 ET
|
Immuneering Corporation
CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop universal-RAS/RAF medicines for broad populations of...
Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
30. Januar 2024 08:30 ET
|
Entera Bio Ltd.
JERUSALEM, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced...
APTIM Selected by U.S. Department of Energy to Decommission Ion Beam Facility
15. August 2023 08:00 ET
|
APTIM
Baton Rouge, La., Aug. 15, 2023 (GLOBE NEWSWIRE) -- The U.S. Department of Energy (DOE) has selected APTIM to deactivate, decommission, and remove (DD&R) the Ion Beam Facility (IBF), a former...
Historic Newsreel Clip: Oppenheimer Issues Warning
21. Juli 2023 22:45 ET
|
UCLA Film & Television Archive
Los Angeles, CA, July 21, 2023 (GLOBE NEWSWIRE) -- Clip from Oct. 26, 1945; 50 seconds: ATOM BOMB SCIENTIST WARNS AMERICA OF DANGERS AHEAD! Research chief of atomic project, Dr. J. Robert...
Creative Mammals Revealed as Animation Studio Behind NBC News Studios' ‘To End All War: Oppenheimer & The Atomic Bomb’
07. Juli 2023 10:00 ET
|
Creative Mammals
Film airs July 9th at 10pm ET on MSNBC; streaming on Peacock Watch the official trailer here ATLANTA, July 07, 2023 (GLOBE NEWSWIRE) -- Creative Mammals is proud to announce its first...
H&R Block to Participate in the Oppenheimer 23rd Annual Consumer Growth & E-Commerce Conference
30. Mai 2023 16:35 ET
|
HRB Tax Group, Inc.
KANSAS CITY, Mo., May 30, 2023 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) (the “Company”) today announced that Jeff Jones, President and Chief Executive Officer, and Tony Bowen, Chief...
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
14. März 2023 08:30 ET
|
Novan, Inc.
DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
Synlogic to Present at the Oppenheimer 33rd Annual Healthcare Conference
08. März 2023 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B....
Processa Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
07. März 2023 08:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, March 07, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), the developer of the Next Generation Chemotherapy drugs that will provide...